Theme of the Congress: Managing Kidney Disease: Quality, Perfection vs. Outcome Wednesday, 5 March 2014 There will whole one day Practical PD course for restricted number of Attendee 20-30 participants. This will include at the end two important sessions: i. Meet the Experts and ii. PD in Arabic countries. Time Date Small Theater lecture 10:00 12:45 12:45 13:15 CNE Continuous Nursing Education 13:15 16:45 17:00 17:30 17:30 19:00 Opening Cermoney Plenary 1 CNE Coffee Break Continuous Nursing Education 10:00 – 16:45 Pre-Congress CNE / Main Hall Moderator: Prof. Hussein Sheashaa 10:00 – 16:45 Pre-Congress Continuous Nursing Education / Lecture Hall 10:00 –16:45 Moderator: Prof: Heba Al-Shaar 10:00 –11:00 11:00-11:45 Clinical Nephrology HD – Maintenance 11:45-12:00 Coffee Break 12:00-13:00 13:00-14: 00 CRRT & ICU PD: Initiation & Maintained 14:00-14:30 Lunch 14:30-15:30 15:30-16:30 16:30 – 16:45 Transplantation TBA Practical Training TBA Evaluation & Closing Remarks Heba Al. Shaar TBA TBA Ib. Sobhy TBA Pre-Congress Practical Training / Entrance Hall 10:00 – 16:00 CRRT PD HD USS & Kidney Biopsy TBA Osama Al-Shaata Sherif Aziz Sherif Hegab M. Al-Shafee Alexandria Mansoura Alexandria Alexandria & Alexandria 17:00 – 17:30 Opening Ceremony / Main Hall Chairpersons: Saeed M. G. Al-Ghamdi, Tarek El-Baz 17:30 – 19:00 Plenary Session / Main Hall P1: Nephrology 2020 Rashad Barsoum Egypt P2: Role of Antibody in transplant rejection M. Al Sayeg Lebanon 19:00 – 20:00 Oriental Music / Main Hall Thursday, 6 March 2014 A Greco Roman Session (S4-Case) Session (S5-G) Session (S6-Tx) Session (S7-Bone) Session (S8-Free Communications) AstraZeneca industrial lunch 15:00 16:00 16:00 17:30 17:30 19:00 CPC -1 Session (S2-Tx) Session (S3-PD) 13:30 15:00 Plenary Session (S1-DKD) 12:30 13:30 Amgen Industrial syposium Lecture 10:45 12:15 Novartis Industrial syposium Small Theater 0900 10:45 Plenary Date Main Hall 08:00 09:00 Global Kidney Academy (GKA/OLA) Time 09:00 – 10:45 Plenary Session / Main Hall Chairpersons: P3: TBA Saeed Al-Ghamdi KSA P4: CKD; Screen or Not- How, Whom and Who? Richard J Glassock USA P5: Membranous nephropathy: from the bench to the bedside? TBA TBA 10:45 – 12:15 Scientific Session (S1) / Main Hall Diabetic Kidney Disease Moderator: Amr Ebied 1) Immune-Inflammation in DKD; pathogenic role and its therapeutic implications. Amr Ebied Egypt 2) FGF-23: role in progression of DKD. TBA TBA 3) Tubulo-interstitial fibrosis in DKD. Update in the pathogenesis. TBA TBA 4) Treatment of Diabetes in CKD – Stage 1-4 Yahiya Ghana Egypt 5) New therapeutic options in DKD TBA TBA 10:45 – 12:15 Scientific Session (S2) / Small Theater Transplantation – 1 Moderator: Adel Bakr 1) 2) 3) 4) Bridge to transplant T-reg in Renal Transplant Desensitization Quiz Marwan Al-Masry M. Sayeg TBA Ahmed Donia Lebanon USA TBA Egypt 10:45 – 12:15 Scientific Session (S3) / Lecture Hall Peritoneal Dialysis Moderator: Salah Naga 1) PD in the challenging population Joanne Bergman Canada 2) The benefits of the new PD Solutions Ali Aboalfa Lebanon 3) Peritonitis management in PD patients: 2013 update Yassin El Shahat UAE 4) PD in AKI Abdalla Alhawish KSA 5) New strategies for growth of PD program Khalid AboSeif Egypt 10:45 – 12:15 Scientific Session (S4) / Hall A Case presentation Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany Each Case will be selected to presented in 15 min (12 min ppt & 3 min for discussion) 12:30 -13:30 Novartis Industrial Symposium / Main Hall 13:30 – 15:00 Scientific Session (S5) / Main Hall Glomerular Diseases Moderator: Iman Al-Gohary The podocytopathies: molecular mechanisms & clinical implications Neveen A Soliman Egypt Immunotactoid vs. Fibrillary GN – A management problem Hayam Al Aggan Egypt Treatment of FSGS – A mysterious Disease to treat? R. Glassock USA New therapy for Glomerular Diseases "Practical or Theoretical – Fact or Fiction" Muhammad Sobh Egypt Stem Cell Therapy in Glomerular Disease: Fact or Fiction? Gamal Al-Saady Egypt 13:30 – 15:00 Scientific Session (S6) / Small Theater Transplantation – 2 Moderator: Adel Bakr 5) Optimizing graft outcome in renal transplantation: Does Pharmacogenetics has a role? Antoine Barbari Lebanon 6) Induction in Renal Transplantation – How; When, Which to use? -Does it really have a value? TBA TBA 7) BK in Renal Transplantation - Update M GhonimatJordan 8) Transplant forum Aymen Refaie Egypt 13:30 – 15:00 Scientific Session (S7) / Lecture Hall CKD-MBD Moderator: Saeed Al-Ghamdi 1) The initiative factor for CKD-MBD – Does it matter to Know? TBA TBA 2) Bone of Glass & Heart of Stone Tarek ElBaz Egypt 3) Phosphate Binders in CKD Magdy Al Sharkawy 4) Egypt Intravenous alfacalcidol in CKD MBD Kiriaki Stamatelou Greece 5) (KDIGO) Guidelines for CKD-MBD: Implementation and Adaptation for Practice in the Middle East Countries. Mona Al Rukhaimi UAE 13:30 – 15:00 Scientific Session (S8) / Hall A Free Paper Communications Moderators: A. Samy, Hyam AlAggan, Sohair Al-Lakany Chairpersons: Mini Lecture: Kidney stone disease, epidemiology and latest therapy Kiriaki Stamatelou Greece 6 papers will be presented. Each paper will be presented for 15min (12 min ppt & 3 min discussion). 15:00 -16:00 Amgen Industrial Symposium / Main Hall 16:00 – 17:30 Plenary Session / Main Hall Chairpersons: P6: GFR and Albuminuria : Risk Predictors for CKD? M. El-Nahas UK P7: Advances in immunosuppression therapy monitoring Marwan Al-Masry Lebnon P8: Nephrotoxicity ,clinical applications Marc deBroe Belgium 17:30 – 19:00 CPC -1 / Main Hall Moderators: Clinical Discussant: Assem Al-Sherif Pathological Discussant: Lina Assad 1st Case: Nahed Baddour Alexandria 2nd Case: TBA TBA 3rd Case: Issam Francis Kuwait 4th Case: TBA Jordon 21:00 – 23:00 Faculty Dinner Small Theater Lecture A Plenary Main Hall 10:30 12:00 12:00 1300 Session (S9-HTN) Coffee Session Break & (S10-HD1) Jomaa Session prayer (S11-Path) Session (S12-Junior) 13:00 14:00 14:00 15:30 15:30 16:30 16:30 18:00 ISN/EDTA CPC -2 09:00 10:30 industrial symposium Time Date Sanofi industial symposium Friday, 7 March 2014 09:00 – 10:30 Plenary Session / Main Hall Chair Persons: P9: Sugar, Uric Acid, Diabetes and Obesity – Do we have a link? RJ Johnson USA P10: Choosing the Right Dialysis Modality for Each Patient: PD versus HD Joanne Bergman Canada P11: Maintenance Immunosuppression in Renal Transplantation; does it affect Graft survival? Maher F. Ramzy Egypt 10:30 – 12:00 Scientific Session (S9) / Main Hall Hypertension Moderator: Omar Al-Kashab 1) Variability of blood pressure in CKD - impact on prescription TBA TBA 2) Home blood pressure versus office blood pressure TBA TBA 3) New guidelines in blood pressure goals in CKD Omar Al-Kashab Egypt Debate: 4) RAS inhibitors/blockers is the first antihypertensive choice in CKD Pros Richard Johnson USA 5) RAS inhibitors/blockers is not the first antihypertensive choice in CKD Cons Meguid El-Nahas UK Rebuttal 5 min each Vote 5 min 10:30 – 12:00 Scientific Session (S10) / Small Theater Hemo-Dialysis/CRRT-1 Moderator: Waleed Masoud 1) Intra and inter dialytic Na and volume control Sohair Al-Lakany Egypt 2) Optimizing removal of middle and large uremic toxins: role of membrane, treatment modality and time B. Canaud France 3) Are we preparing the patient for hemodialysis in Egypt: Preparation of the patient for hemodialysis: Guidelines vs. TBA TBA Egypt vs. Waleed Masoud Egypt Voting TBA TBA 4) AVF Button Technique M. Jadoul France 10:30 – 12:00 Scientific Session (S11) / Lecture Hall Renal Pathology Moderator: Issam Francis, Lina Assad, Wesam Ismail Chairpersons: 1) C3 GN – Update in MPGN Classification– Pathological View Fatma Al Huseiny Egypt 2) Interstitial Nephritis – pathological entity without boundaries TBA TBA 3) Hereditary Nephritis – Does Pathology help? TBA TBA 4) Pathological Case (1) Lina Assad Syria 5) Pathological Case (2) Wesam Ismail Egypt 10:30 – 12:00 Scientific Session (S12) / Hall A Free Junior Communications Moderators: Hussein Sheashaa, M. Salah, A. Adam 9 free junior communications will be selected to be presented. Each presentation will take 10 min (8 min ppt & 2 min Discussion) 12:00 – 13:00 Coffee Break & Gomaa Pray 13:00 - 14:00 Sanofi Industrial Symposium / Main Hall 14:00 – 15:30 ISN / EDTA Satellite Session / Main Hall Chairperson: G Remuzzi Italy DOPPS – Update Michel Jadoul Belgium Onco-nephrology: glomerular diseases with cancer. TBA TBA Donor / Recipient relationship in renal transplantation in the Arabic world Mona Al Rukhaimi UAE "0 by 25" A human rights case for health equity: acute kidney failure in poor countries should no longer be a death sentence" G Remuzzi Italy 15:30 - 16:30 Industrial Symposium / Main Hall 16:30 – 18:00 CPC -2 / Main Hall Moderators: Clinical Discussant: Riyad Said Pathological Discussant: Issam Francis 5th Case: TBA Mansoura 6th Case: TBA Cairo 7th Case: TBA KSA 8th Case: TBA Ein Shams 21:00 – 23:00 Gala Dinner Friday Jordon Kuwait Date 0900 10:45 10:45 11:45 11:45 12:15 12:15 14:15 14:15 Session (S13-Prog) Session (S14Epidemiology) Session (S15-WKD) Session (S16-HD2CRRT) Departure Time Coffee Break Saturday, 8 March 2014 Lecture A Kidney Forum Small Theater Plenary Closing Remarks Main Hall 09:00 – 10:45 Plenary Session / Main Hall Chairpersons: P12: The impact of viruses and their treatment on the kidney Michel Jadoul Belgium P13: APK; still Unsolved Management Problem? G. Remuzzi Italy P14: The Transplantation in the Arabic World Faisel Shaeen KSA 10:45 – 11:45 Kidney Forum / Main Hall Chairpersons: R. Barsoum Clinical Discussant: M. Jadoul & Antoine Barbari Pathological Discussant: Mona Salem & Wesam Ismail 11:45 – 12:00 Closing Remarks / Main Hall Charipersons: Tarek ElBaz, G. Remuzzi 12:15 – 14:15 Scientific Session (S13) / Main Hall Progression of CKD - CKD: Contrarian Views! Moderator: Abdel Meguid El-Nahas 1) Progression, remission and regression of chronic renal diseases and the case of kidney self-repair G. Remuzzi Italy 2) Reflections on with Current CKD Guidelines Richard Glassock USA 3) 4) 5) CKD – Care Pathway? Marc de Broe Belgium eGFR: What for? Abdel Meguid El Nahas UK Genetics of CKD; Does it help to Manage Progression? Neveen Soliman ElShakhs Egypt 12:15 – 14:15 Scientific Session (S14) / Small Theater Epidemiology of Kidney Diseases Moderator: Hala El-Wakeel 1) Non-Communicable diseases as global and regional problems. Alaa Alwan EMRO-WHO 2) Screening for CKD in KSA as a part of the Arabic World. TBA TBA 3) Kidney protection program in Alexandria region "KIPP-Alex". Hala El-Wakil Egypt 4) Control Program for non-communicable diseases- Environmental-Health Link. Moustafa Mourad HIPH- Alex 12:15 – 14:15 Scientific Session (S15) / Lecture Hall WKD – 2014 – “ CHRONIC KIDNEY DISEASE AND AGING”. Moderator: Hany Hafez Chairpersons: 1) Introduction :Various scientific activities of ESNT Tarek El-Baz Egypt 2) What Did World Kidney Days added (Flash back of last 5 years activities) Mohamed Hani Hafez Egypt 3) How Aging Affects Normal Kidneys. TBA TBA 4) CKD patients & aging : specific Considerations for CKD, Dialysis & Transplantation populations Richard Glassock USA 12:15 – 14:15 Scientific Session (S16) / Hall A Hemo-Dialysis- 2 AKI- CRRT- ICU Nephrology Moderator: Montassar Zeid Chairpersons: Bioimpedence in HD Ahmed Samy ElBelbessy Egypt Concurrent CRRT and therapeutic plasma exchange Montassar Zeid Egypt Extended indications for CRRT Saeed Khamis Egypt Dialysis dose controversy: what role for Kt/V in future ? G Canaud France
© Copyright 2024 ExpyDoc
